Goal 3: Advance Translational Research

Facilitation of adoption of evidence-based guidelines in clinical practice for CVD risk factor identification and treatment

Multiple factors contribute to the high mortality from heart and vascular diseases in our population, most prominently genetics, patient behavior, care access, and care quality. Historically, interventions have targeted patient behaviors. Though access remains a problem, those who do receive care may not be getting the best of care based on the evidence. A focus on increasing practitioner adoption of evidence-based ...more »

Submitted by (@rubybenjamingarner)

Voting

1 net vote
3 up votes
2 down votes
Active

Goal 3: Advance Translational Research

To Improve Clinical Practice Recommendations for Asthma

What are the strategies to improve the use of evidence-based clinical practice recommendations and thereby increase the quality of care and improve outcomes for people with asthma? • Lack of provider awareness, knowledge, agreement, and/or self-efficacy in using the guidelines • Inconsistent use of guidelines-based asthma care in clinical practice. • Scarce/limited resources and limited access to target audiences. • ...more »

Submitted by (@nhlbiforumadministrator)

Voting

1 net vote
6 up votes
5 down votes
Active

Goal 1: Promote Human Health

Qigong and Tai Chi for Chronic Disease Prevention

Non-pharmacological interventions for pain and stress have gained tremendous momentum. Mind-Body Practice -- Qigong and Tai Chi -- are group based and inexpensive to implement. The evidence base suggests that these practices are safe and effective for a multitude of preventable chronic disorders.. THE QUESTION: Given safety and efficacy, should there be vigorous research on implementation of Qigong and Tai Chi and ...more »

Submitted by (@rogerjahnke)

Voting

2 net votes
33 up votes
31 down votes
Active

Goal 3: Advance Translational Research

ASCVD Risk and Treatment Options

There is little evidence about the best ways in which to effectively communicate atherosclerotic cardiovascular disease (ASCVD) risk to patients so that they clearly understand the potential benefits and harms of treatments in order to make informed decisions about their care. A shift toward shared decision-making and tailored treatment makes it imperative that effective risk communication strategies be developed and ...more »

Submitted by (@nhlbiforumadministrator)

Voting

-2 net votes
6 up votes
8 down votes
Active